The aim of this literature review was to identify risk factors in addition to antimicrobial treatment for antimicrobial resistance (AMR) occurrence in commensal Escherichia coli in pigs. A variety of studies were searched in 2014 and 2015. Studies identified as potentially relevant were assessed against eligibility criteria such as observation or experiment (no review), presentation of risk factors in addition to (single dosage) antimicrobial use, risk factors for but not resulting from AMR, and the same antimicrobial used and tested. Thirteen articles (nine on observational, four on experimental studies) were finally selected as relevant. It was reported that space allowance, production size/stage, cleanliness, entry of animals and humans into herds, dosage/frequency/route of administration, time span between treatment and sampling date, herd size, distance to another farm, coldness, and season had an impact on AMR occurrence. Associations were shown by one to four studies per factor and differed in magnitude, direction, and level of significance. The risk of bias was unclear in nearly half of the information of observational studies and in most of the information from experimental studies. Further research on the effects of specific management practices is needed to develop well-founded management advice.
Get full access to this article
View all access options for this article.
References
1.
UngemachF.R., Mueller-BahrdtD., and AbrahamG.2006. Guidelines for prudent use of antimicrobials and their implications on antibiotic usage in veterinary medicine. Int. J. Med. Microbiol., 296:33–38.
2.
MerleR., HajekP., KasbohrerA., Hegger-GravenhorstC., MollenhauerY., RobanusM., UngemachF.R., and KreienbrockL.2012. Monitoring of antibiotic consumption in livestock: a German feasibility study. Prev. Vet. Med., 104:34–43.
KreienbrockL., HemmeM., and HartmannM.2015. Aktueller Stand der Untersuchungen zum Antibiotikaeinsatz in der Tierhaltung. Abstract presented at the 2nd BfR-Symposium Antibiotikaresistenz in der Lebensmittelkette, Berlin, November. 2–3. Abstract no. 3.8. (In German.)
BurowE., SimoneitC., TenhagenB.A., and KasbohrerA.2014. Oral antimicrobials increase antimicrobial resistance in porcine E. coli—a systematic review. Prev. Vet. Med., 113:364–375.
7.
HunterJ.E.B., ShelleyJ.C., WaltonJ.R., HartC.A., and BennettM.. 1992. Apramycin resistance plasmids in Escherichia coli—possible transfer to Salmonella typhimurium in calves. Epidemiol. Infect., 108:271–278.
8.
CiorbaV., OdoneA., VeronesiL., PasquarellaC., and SignorelliC.2015. Antibiotic resistance as a major public health concern: epidemiology and economic impact. Ann. Ig., 27:562–579.
9.
CohenM.L.1992. Epidemiology of drug-resistance—implications for a postantimicrobial era. Science, 257:1050–1055.
10.
TaylorN.M., Clifton-HadleyF.A., WalesA.D., RidleyA., and DaviesR.H.2009. Farm-level risk factors for fluoroquinolone resistance in E. coli and thermophilic Campylobacter spp. on finisher pig farms. Epidemiol. Infect., 137:1121–1134.
11.
RosengrenL.B., WaldnerC.L., Reid-SmithR.J., DowlingP.M., and HardingJ.C.2007. Associations between feed and water antimicrobial use in farrow-to-finish swine herds and antimicrobial resistance of fecal Escherichia coli from grow-finish pigs. Microb. Drug Resist., 13:261–269.
12.
HigginsJ.P.T., AltmanD.G., GotzscheP.C., JuniP., MoherD., OxmanA.D., SavovicJ., SchulzK.F., WeeksL., and SterneJ.A.C.; Cochrane Bias Methods Group and Cochrane Statistical Methods Group. 2011. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br. Med. J., 343:9.
13.
KimS.Y., ParkJ.E., LeeY.J., SeoH.J., SheenS.S., HahnS., JangB.H., and SonH.J.2013. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J. Clin. Epidemiol., 66:408–414.
14.
VieiraA.R., HoueH., WegenerH.C., WongD., and EmborgH.D.2009. Association between tetracycline consumption and tetracycline resistance in Escherichia coli from healthy Danish slaughter pigs. Foodborne Pathog. Dis., 6:99–109.
15.
TaylorN.M., DaviesR.H., RidleyA., CloutingC., WalesA.D., and Clifton-HadleyF.A.2008. A survey of fluoroquinolone resistance in Escherichia coli and thermophilic Campylobacter spp. on poultry and pig farms in Great Britain. J. Appl. Microbiol., 105:1421–1431.
16.
LutzE.A., Mc CartyM.J., MollenkopfD.F., FunkJ.A., GebreyesW.A., and WittumT.E.2011. Ceftiofur use in finishing swine barns and the recovery of fecal Escherichia coli or Salmonella spp. Resistant to Ceftriaxone. Foodborne Pathog. Dis., 8:1229–1234.
17.
MathewA.G., ArnettD.B., CullenP., and EbnerP.D.2003. Characterization of resistance patterns and detection of apramycin resistance genes in Escherichia coli isolated from swine exposed to various environmental conditions. Int. J. Food Microbiol., 89:11–20.
18.
LangloisB.E., DawsonK.A., StahlyT.S., and CromwellG.L.1984. Antibiotic-resistance of fecal coliforms from swine fed subtherapeutic and therapeutic levels of chlortetracycline. J. Anim. Sci., 58:666–674.
19.
AkwarH.T., PoppeC., WilsonJ., Reid-SmithR.J., DyckM., WaddingtonJ., ShangD., and McEwenS.A.2008. Associations of antimicrobial uses with antimicrobial resistance of fecal Escherichia coli from pigs on 47 farrow-to-finish farms in Ontario and British Columbia. Can. J. Vet. Res., 72:202–210.
20.
DunlopR.H., McEwenS.A., MeekA.H., ClarkeR.C., BlackW.D., and FriendshipR.M.1998. Associations among antimicrobial drug treatments and antimicrobial resistance of fecal Escherichia coli of swine on 34 farrow-to-finish farms in Ontario, Canada. Prev. Vet. Med., 34:283–305.
21.
DelsolA.A., AnjumM., WoodwardM.J., SunderlandJ., RoeJ.M., DelsolA.A., AnjumM., WoodwardM.J., SunderlandJ., and RoeJ.M.2003. The effect of chlortetracycline treatment and its subsequent withdrawal on multi-resistant Salmonella enterica serovar Typhimurium DT104 and commensal Escherichia coli in the pig. J. Appl. Microbiol., 95:1226–1234.
22.
WagnerB.A., StrawB.E., Fedorka-CrayP.J., and DargatzD.A.2008. Effect of antimicrobial dosage regimen on Salmonella and Escherichia coli isolates from feeder swine. Appl. Environ. Microbiol., 74:1731–1739.
23.
MathewA.G., JacksonF., and SaxtonA.M.2002. Effects of antibiotic regimens on resistance of Escherichia coli and Salmonella serovar Typhimurium in swine. J. Swine Health Prod., 10:7–13.
24.
AlaliW.Q., ScottH.M., HarveyR.B., NorbyB., LawhornD.B., and PillaiS.D.2008. Longitudinal study of antimicrobial resistance among Escherichia coli isolates from integrated multisite cohorts of humans and swine. Appl. Environ. Microbiol., 74:3672–3681.
25.
DewulfJ., CatryB., TimmermanT., OpsomerG., de KruifA., and MaesD.2007. Tetracycline-resistance in lactose-positive enteric coliforms originating from Belgian fattening pigs: degree of resistance, multiple resistance and risk factors. Prev. Vet. Med., 78:339–351.
26.
AkwarH.T., PoppeC., WilsonJ., Reid-SmithR.J., DyckM., WaddingtonJ., ShangD., and McEwenS.A.2008. Prevalence and patterns of antimicrobial resistance of fecal Escherichia coli among pigs on 47 farrow-to-finish farms with different in-feed medication policies in Ontario and British Columbia. Can. J. Vet. Res., 72:195–201.
27.
VargaC., RajicA., McFallM.E., Reid-SmithR.J., DeckertA.E., CheckleyS.L., and McEwenS.A.2009. Associations between reported on-farm antimicrobial use practices and observed antimicrobial resistance in generic fecal Escherichia coli isolated from Alberta finishing swine farms. Prev. Vet. Med., 88:185–192.
28.
AlaliW.Q., ScottH.M., ChristianK.L., FajtV.R., HarveyR.B., and LawhornD.B.2009. Relationship between level of antibiotic use and resistance among Escherichia coli isolates from integrated multi-site cohorts of humans and swine. Prev. Vet. Med., 90:160–167.
29.
van RenningsL., von MunchhausenC., OttilieH., HartmannM., MerleR., HonschaW., KasbohrerA., and KreienbrockL.2015. Cross-sectional study on antibiotic usage in pigs in Germany. PLoS One, 10:e0119114.
30.
MurphyC.P., FajtV.R., ScottH.M., FosterM.J., WickwireP., and McEwenS.A.2015. Scoping review to identify potential non-antimicrobial interventions to mitigate antimicrobial resistance in commensal enteric bacteria in North American cattle production systems. Epidemiol. Infect., 144:1–18.
31.
HeringJ., HilleK., FromkeC., von MunchhausenC., HartmannM., SchneiderB., FrieseA., RoeslerU., MerleR., and KreienbrockL.2014. Prevalence and potential risk factors for the occurrence of cefotaxime resistant Escherichia coli in German fattening pig farms—a cross-sectional study. Prev. Vet. Med., 116:129–137.
32.
LaanenM., PersoonsD., RibbensS., de JongE., CallensB., StrubbeM., MaesD., and DewulfJ.2013. Relationship between biosecurity and production/antimicrobial treatment characteristics in pig herds. Vet. J., 198:508–512.
33.
HybschmannG.K., ErsbollA.K., VigreH., BaadsgaardN.P., and HoueH.2011. Herd-level risk factors for antimicrobial demanding gastrointestinal diseases in Danish herds with finisher pigs: a register-based study. Prev. Vet. Med., 98:190–197.
34.
JensenV.F., EmborgH.D., and AarestrupF.M.2012. Indications and patterns of therapeutic use of antimicrobial agents in the Danish pig production from 2002 to 2008. J. Vet. Pharmacol. Ther., 35:33–46.
35.
SnowL.C., WarnerR.G., CheneyT., WearingH., StokesM., HarrisK., TealeC.J., and ColdhamN.G.2012. Risk factors associated with extended spectrum beta-lactamase Escherichia coli (CTX-M) on dairy farms in North West England and North Wales. Prev. Vet. Med., 106:225–234.
36.
ReistM., GeserN., HachlerH., ScharrerS., and StephanR.2013. ESBL-producing Enterobacteriaceae: occurrence, risk factors for fecal carriage and strain traits in the Swiss slaughter cattle population younger than 2 years sampled at abattoir level. PLoS One, 8:e71725.
37.
Sternberg LewerinS., OsterbergJ., AleniusS., ElvanderM., FellstromC., TravenM., WallgrenP., WallerK.P., and JacobsonM.2015. Risk assessment as a tool for improving external biosecurity at farm level. BMC Vet. Res., 11:171.
38.
BackhansA., SjolundM., LindbergA., and EmanuelsonU.2015. Biosecurity level and health management practices in 60 Swedish farrow-to-finish herds. Acta Vet. Scand., 57:14.
39.
CallensB., FaesC., MaesD., CatryB., BoyenF., FrancoysD., de JongE., HaesebrouckF., and DewulfJ.2015. Presence of antimicrobial resistance and antimicrobial use in sows are risk factors for antimicrobial resistance in their offspring. Microb. Drug Resist., 21:50–58.
40.
ScherzG., StahlJ., GlunderG., and Kietzmann MM.2014. Effects of carry-over of fluoroquinolones on the susceptibility of commensal Escherichia coli in the intestinal microbiota of poultry. Berl. Munch. Tierarztl. Wochenschr., 127:478–485.
41.
FrieseA., SchulzJ., LaubeH., von SalviatiC., HartungJ., and RoeslerU.2013. Faecal occurrence and emissions of livestock-associated methicillin-resistant Staphylococcus aureus (laMRSA) and ESbl/AmpC-producing E. coli from animal farms in Germany. Berl. Munch. Tierarztl. Wochenschr., 126:175–180.
42.
LaubeH., FrieseA., von SalviatiC., GuerraB., and RoslerU.2014. Transmission of ESBL/AmpC-producing Escherichia coli from broiler chicken farms to surrounding areas. Vet. Microbiol., 172:519–527.
43.
von SalviatiC., LaubeH., GuerraB., RoeslerU., and FrieseA.2015. Emission of ESBL/AmpC-producing Escherichia coli from pig fattening farms to surrounding areas. Vet. Microbiol., 175:77–84.
44.
DuanH.Y., ChaiT.J., CaiY.M., ZhongZ.B., YaoM.L., and ZhangX.X.2008. Transmission identification of Escherichia coli aerosol in chicken houses to their environments using ERIC-PCR. Sci. China Ser. C Life. Sci., 51:164–173.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
